4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2009-0339, INC07-10-01, HP-00043796, IRB-AAAE3596, 09-163, 1002010885, S500/409, H-2009-0106, I 162709, 0910M73354, 200912711, UAB 0964, NCT00951379
|